Infliximab Re-treatment in Inflammatory Bowel Disease: A Single-Center Routine Clinical Experience.
Department of Medicine, Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Julia T
JT
Hughes
Department of Medicine, Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Hans H
HH
Herfarth
Department of Medicine, Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Kim L
KL
Isaacs
Department of Medicine, Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Scott E
SE
Plevy
Department of Medicine, Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
R Balfour
RB
Sartor
Department of Medicine, Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Shehzad Z
SZ
Sheikh
Department of Medicine, Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Jonathan J
JJ
Hansen
Department of Medicine, Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Millie D
MD
Long
D000906:Antibodies / Q000097:blood*; D000911:Antibodies, Monoclonal / Q000276:immunology* / Q000493:pharmacokinetics*; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000276:immunology* / Q000493:pharmacokinetics*; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D008297:Male; D011247:Pregnancy
D000906:Antibodies; D000911:Antibodies, Monoclonal; D007155:Immunologic Factors